Latest Breaking News On - Carryn anderson - Page 1 : comparemela.com

Galera Therapeutics : Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives with decades of experience successfully launching and commercializing new oncology products - Form 8-K

Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives. | May 11, 2023

United statesSan antonioChristopher degnanMel sorensenCarryn andersonLorraine walkerMark bachledaElizabeth cullenWilliam windhamZara lockshinGalera therapeutics incExchange commissionCompany viceOncology nursing societyEuropean congress on headUniversity of iowa

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMel sorensenCarryn andersonZara lockshinsolebury strategic communicationsUniversity of iowaChristopher degnangalera therapeutics incExchange commissionWilliam windhamsolebury strategic communicationsAmerican society for radiation oncologyGalera therapeutics incWall streetRadiation oncologyClinical associate professorSevere oral mucositisFast trackBreakthrough therapy

Galera Therapeutics (GRTX) Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology

Galera Therapeutics (GRTX) Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMel sorensenCarryn andersonAmerican society for radiation oncologyAmerican society of clinical oncologyUniversity of iowaGalera therapeutics incRadiation oncologyClinical oncologyClinical associate professor

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting

United statesChristopher degnanMel sorensenZara lockshinWilliam windhamCarryn andersonExchange commissionAmerican society for radiation oncologyUniversity of iowaGalera therapeutics incSolebury strategic communicationsRadiation oncologyClinical associate professorSevere oral mucositisFast trackBreakthrough therapy

Novel Agent Lessens Mucositis in Head and Neck Cancers

IV infusion could allow more patients to complete treatment regimen

United statesIowa cityFort pierceEd susmanJames bonnerCarryn andersonAmerican society of clinical oncologyUniversity of iowaUniversity of alabama at birminghamAmerican societyClinical oncology

Latest Breaking News On - Carryn anderson - Page 1 : comparemela.com

Galera Therapeutics : Company raised $30 million in gross proceeds from registered direct offering Company expanded commercial team and appointed leading biopharmaceutical executives with decades of experience successfully launching and commercializing new oncology products - Form 8-K

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting

Galera Therapeutics (GRTX) Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology

Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting

Novel Agent Lessens Mucositis in Head and Neck Cancers

IV infusion could allow more patients to complete treatment regimenUnited statesIowa cityFort pierceEd susmanJames bonnerCarryn andersonAmerican society of clinical oncologyUniversity of iowaUniversity of alabama at birminghamAmerican societyClinical oncology

IV infusion could allow more patients to complete treatment regimen

United statesIowa cityFort pierceEd susmanJames bonnerCarryn andersonAmerican society of clinical oncologyUniversity of iowaUniversity of alabama at birminghamAmerican societyClinical oncology